Clinical Trials Directory

Trials / Completed

CompletedNCT02241915

Use of a Microbial Sealant to Reduce Surgical Site Infections.

Microbial Sealants Do Not Decrease Surgical Site Infection for Clean Contaminated Colorectal Procedures.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Surgical site infections (SSI) are costly complications that may cause significant morbidity and increase the cost of care, particularly in colorectal surgery. Microbial sealants (MS) are a new class of wound barriers aimed at decreasing SSI, however there is only evidence of benefit in clean Class 1 procedures. Based on its success in Class 1 procedures, we hypothesized that a microbial sealant could reduce the rate of SSI by half for clean contaminated colorectal procedures (Class 2).

Conditions

Interventions

TypeNameDescription
PROCEDUREOpen Colorectal Surgery
PROCEDURELaparoscopic Surgery

Timeline

Start date
2011-01-01
Primary completion
2012-05-01
First posted
2014-09-16
Last updated
2014-09-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02241915. Inclusion in this directory is not an endorsement.